NMTC Insider Trading Activity and SEC Form 4 Filings
NMTC insider trading summary
Over the past 12 months, insiders at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) reported 6 sales worth $55K by 1 insider and 2 open-market purchases worth $737K by 1 insider on SEC Form 4. Net insider buying was $683K.
Latest NMTC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 27, 2026 | David J. Wambeke | Chief Business Officer | Buy | $67K (33,333 @ $2.01) |
| Jun 30, 2026 | Mark Christianson | Market Development Director | Sell | $32K (10,000 @ $3.18) |
| Mar 30, 2026 | Mark Christianson | Business Development Director | Sell | $11K (15,363 @ $0.74) |
| Mar 13, 2026 | Mark Christianson | Business Development Director | Sell | $80 (100 @ $0.80) |
| Mar 12, 2026 | Mark Christianson | Business Development Director | Sell | $654 (817 @ $0.80) |
| Mar 11, 2026 | Mark Christianson | Business Development Director | Sell | $2K (2,109 @ $0.80) |
| Mar 10, 2026 | Mark Christianson | Business Development Director | Sell | $9K (11,611 @ $0.80) |
| Mar 1, 2026 | David J. Wambeke | Chief Business Officer | Buy | $670K (1,000,000 @ $0.67) |
| Sep 5, 2025 | Mark Christianson | Business Development Director | Sell | $22K (30,000 @ $0.74) |
| Jun 4, 2025 | Mark Christianson | Business Development Director | Sell | $6K (10,000 @ $0.58) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.